AAP
Aristotle Atlantic Partners Portfolio holdings
AUM
$3.29B
This Quarter Return
+10.82%
1 Year Return
+24.5%
3 Year Return
+129.49%
5 Year Return
+188.87%
10 Year Return
–
AUM
$1.72B
AUM Growth
+$1.72B
(+14%)
Cap. Flow
+$78.9M
Cap. Flow
% of AUM
4.58%
Top 10 Holdings %
Top 10 Hldgs %
43.42%
Holding
104
New
5
Increased
59
Reduced
9
Closed
3
Top Buys
| 1 |
Synopsys
SNPS
|
$14.8M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$10M |
| 3 |
CrowdStrike
CRWD
|
$9.2M |
| 4 |
Apple
AAPL
|
$6.65M |
| 5 |
Microchip Technology
MCHP
|
$5.97M |
Top Sells
| 1 |
Teleflex
TFX
|
$17.9M |
| 2 |
Qorvo
QRVO
|
$12.5M |
| 3 |
NVIDIA
NVDA
|
$12.3M |
| 4 |
Merck
MRK
|
$3.9M |
| 5 |
Bristol-Myers Squibb
BMY
|
$1.97M |
Sector Composition
| 1 | Technology | 31.45% |
| 2 | Healthcare | 17.04% |
| 3 | Consumer Discretionary | 13.41% |
| 4 | Industrials | 10.91% |
| 5 | Financials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
DexCom
DXCM
$29.1B
| $21.6M | 1.25% |
40,216
+194
| +0.5% | +$104K |
|
27
Global Payments
GPN
$21.1B
| $21.6M | 1.25% |
159,446
+3,314
| +2% | +$448K |
|
28
Adaptive Biotechnologies
ADPT
$2.01B
| $20.9M | 1.21% |
745,795
+18,461
| +3% | +$518K |
|
29
Guardant Health
GH
$8.29B
| $20.2M | 1.17% |
202,353
+7,423
| +4% | +$742K |
|
30
Twilio
TWLO
$16B
| $20.2M | 1.17% |
76,769
+531
| +0.7% | +$140K |
|
31
Roper Technologies
ROP
$56.6B
| $17.6M | 1.02% |
35,856
+20
| +0.1% | +$9.84K |
|
32
Exxon Mobil
XOM
$489B
| $15.5M | 0.9% |
253,482
| – | – |
|
33
Snowflake
SNOW
$77.9B
| $15.2M | 0.88% |
44,732
+1,180
| +3% | +$400K |
|
|
34
Synopsys
SNPS
$112B
| $14.8M | 0.86% |
+40,090
| New | +$14.8M |
|
35
Broadcom
AVGO
$1.4T
| $13.7M | 0.79% |
20,550
+1,998
| +11% | +$1.33M |
|
36
Ameriprise Financial
AMP
$48.5B
| $13.3M | 0.77% |
44,118
+5,205
| +13% | +$1.57M |
|
37
Marriott International Class A Common Stock
MAR
$72.7B
| $12M | 0.69% |
72,336
+14,403
| +25% | +$2.38M |
|
38
American Tower
AMT
$93.9B
| $11.7M | 0.68% |
40,000
| – | – |
|
39
Abbott
ABT
$229B
| $11.6M | 0.67% |
82,246
+30,362
| +59% | +$4.27M |
|
40
Bank of America
BAC
$373B
| $11.2M | 0.65% |
251,129
+50,055
| +25% | +$2.23M |
|
41
Parker-Hannifin
PH
$96.2B
| $10.4M | 0.61% |
32,770
| – | – |
|
|
42
Iovance Biotherapeutics
IOVA
$792M
| $10M | 0.58% |
+525,538
| New | +$10M |
|
|
43
Microchip Technology
MCHP
$34.3B
| $9.95M | 0.58% |
114,278
+68,528
| +150% | +$5.97M |
|
|
44
CrowdStrike
CRWD
$104B
| $9.93M | 0.58% |
48,493
+44,941
| +1,265% | +$9.2M |
|
45
Intercontinental Exchange
ICE
$101B
| $9.24M | 0.54% |
67,578
+13,458
| +25% | +$1.84M |
|
46
PotlatchDeltic
PCH
$3.25B
| $9.13M | 0.53% |
151,661
| – | – |
|
47
Comcast
CMCSA
$126B
| $8.93M | 0.52% |
177,514
+35,377
| +25% | +$1.78M |
|
48
Chubb
CB
$110B
| $8.58M | 0.5% |
44,383
+8,841
| +25% | +$1.71M |
|
|
49
Bristol-Myers Squibb
BMY
$96.5B
| $8.38M | 0.49% |
134,430
-31,655
| -19% | -$1.97M |
|
50
Murphy USA
MUSA
$7.26B
| $8.35M | 0.48% |
41,913
| – | – |
|